Transparency Market Research Report Add "Implantable Drug
Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 – 2019," to its database.
Implantable
Drug Delivery Devices Market was
valued at USD 760 million and is expected to grow
at a CAGR of 21.3% from 2013 to 2019 to reach an estimated value of USD 2,937.3 million by 2019.
Browse the full report at
http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html
Implantable drug delivery devices hold a
competitive edge over other drugs and devices owing to the fact that they are
implanted at targeted sites and so deliver unaltered amounts of drugs to the
affected area. These implantable drug delivery devices are categorized into six
product types and this report estimates their market in terms of USD million,
for the period 2012 - 2018, keeping 2011 as the base year.
The market is segmented on the basis of product types into implantable infusion pumps, brachytherapy seeds, contraceptive implants, drug eluting stents, bio-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest of the world regions (RoW). The market is segmented on the basis of technology into biodegradable and non-biodegradable implant technology and on the basis of applications into oncology, cardiovascular, contraceptive, ophthalmology and others (diabetes, inflammatory conditions).
A competitive landscape, mapping all the market players and their respective market shares for 2011 are provided in this report along with some major business strategies adopted by these players to accentuate market shares. A chapter on recommendations for existing and new entrants is also provided.
Some of the major players profiled in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
Key Topics Covered:
1 Preface
2 Executive Summary
3 Market Overview
4 Implantable Drug Delivery Devices Market, By Product Types
5 Global Implantable Drug Delivery Devices Market, By Technology
6 Global Implantable Drug Delivery Devices Market, By Applications
7 Implantable Drug Delivery Devices Market By Geography
8 Recommendations
9 Competitive Landscape
10 Company Profiles
Companies Mentioned:
The market is segmented on the basis of product types into implantable infusion pumps, brachytherapy seeds, contraceptive implants, drug eluting stents, bio-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest of the world regions (RoW). The market is segmented on the basis of technology into biodegradable and non-biodegradable implant technology and on the basis of applications into oncology, cardiovascular, contraceptive, ophthalmology and others (diabetes, inflammatory conditions).
A competitive landscape, mapping all the market players and their respective market shares for 2011 are provided in this report along with some major business strategies adopted by these players to accentuate market shares. A chapter on recommendations for existing and new entrants is also provided.
Some of the major players profiled in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
Key Topics Covered:
1 Preface
2 Executive Summary
3 Market Overview
4 Implantable Drug Delivery Devices Market, By Product Types
5 Global Implantable Drug Delivery Devices Market, By Technology
6 Global Implantable Drug Delivery Devices Market, By Applications
7 Implantable Drug Delivery Devices Market By Geography
8 Recommendations
9 Competitive Landscape
10 Company Profiles
Companies Mentioned:
- Abbott Laboratories
- Allergan, Inc.
- Bausch & Lomb Inc.
- Bayer Healthcare
- Boston Scientific Corporation
- Medtronic Inc.
- Merck
- Nucletron
- Psivida Corp.
About Us
Transparency Market Research is a global
market intelligence company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information.Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
.
No comments:
Post a Comment